Joel Greenblatt’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-74,344
Closed -$1.1M – 1951
2026
Q2
$1.1M Buy
+74,344
New +$513K ﹤0.01% 1334

Other funds holding SLS

Joel Greenblatt's SLS Position: Q3 2026 in Review

Joel Greenblatt sold out of SELLAS Life Sciences (SLS) in Q3 2026, closing a stake of 74,344 shares — an estimated $1.1M sold.

Joel Greenblatt first reported a position in SLS in Q2 2026 and held it in 1 quarter. The position peaked at $1.1M in Q2 2026. 215 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Joel Greenblatt reported no remaining SELLAS Life Sciences position as of Q3 2026 after selling out during the quarter.
  • Joel Greenblatt sold 74,344 SELLAS Life Sciences shares in Q3 2026, an estimated $1.1M.
  • Joel Greenblatt first reported a position in SELLAS Life Sciences in Q2 2026 and held it in 1 quarter.
  • Joel Greenblatt's SELLAS Life Sciences position peaked at $1.1M in Q2 2026.
  • 215 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.